Precipio, Inc. (NASDAQ:PRPO) Director Richard A. Sandberg Sells 2,000 Shares

Precipio, Inc. (NASDAQ:PRPO) Director Richard A. Sandberg sold 2,000 shares of the business’s stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $6.28, for a total value of $12,560.00. Following the completion of the sale, the director now directly owns 16,525 shares of the company’s stock, valued at $103,777. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

Precipio Stock Up 2.3 %

PRPO opened at $6.14 on Wednesday. The business has a 50 day moving average price of $6.47 and a two-hundred day moving average price of $5.89. The company has a quick ratio of 0.60, a current ratio of 0.73 and a debt-to-equity ratio of 0.02. Precipio, Inc. has a 52 week low of $4.31 and a 52 week high of $8.49.

Precipio (NASDAQ:PRPO) last released its earnings results on Tuesday, August 13th. The biotechnology company reported ($0.83) earnings per share (EPS) for the quarter. Precipio had a negative return on equity of 34.01% and a negative net margin of 17.23%. The business had revenue of $4.44 million for the quarter.

Precipio Company Profile

Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.